We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8B
AUM Growth
+$1.89B
(+9%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
3,143
New
326
Increased
869
Reduced
968
Closed
274
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$125M |
| 2 |
Southwest Airlines
LUV
|
+$121M |
| 3 |
Lam Research
LRCX
|
+$101M |
| 4 |
DuPont de Nemours
DD
|
+$92.3M |
| 5 |
NetApp
NTAP
|
+$74.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$91.2M |
| 2 |
Tyson Foods
TSN
|
+$72.4M |
| 3 |
Merck
MRK
|
+$67.7M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$67.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.59% |
| 2 | Technology | 15.59% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 10.36% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Qiagen
QGEN
$8.53B
| $864K | ﹤0.01% |
25,872
-701
| -3% | -$24.2K |
|
|
SHPG
702
DELISTED
Shire pic
SHPG
| $862K | ﹤0.01% |
5,643
-5,289
| -48% | -$829K |
|
703
Williams-Sonoma
WSM
$26.7B
| $859K | ﹤0.01% |
34,480
+9,908
| +40% | +$230K |
|
704
Alkermes
ALKS
$8.82B
| $841K | ﹤0.01% |
+16,570
| New | +$886K |
|
705
CF Industries
CF
$19.2B
| $841K | ﹤0.01% |
23,936
+4,279
| +22% | +$132K |
|
|
ONCE
706
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $837K | ﹤0.01% |
9,394
+1,092
| +13% | +$82.9K |
|
707
PG&E
PCG
$47.8B
| $836K | ﹤0.01% |
12,288
-8,023
| -40% | -$550K |
|
708
iShares Biotechnology ETF
IBB
$9.31B
| $831K | ﹤0.01% |
7,479
+903
| +14% | +$96.5K |
|
|
PRXL
709
DELISTED
Parexel International Corp
PRXL
| $830K | ﹤0.01% |
9,437
-4,572
| -33% | -$401K |
|
710
Wabtec
WAB
$51.1B
| $824K | ﹤0.01% |
10,903
+4,350
| +66% | +$335K |
|
|
INVX
711
Innovex International
INVX
$1.87B
| $810K | ﹤0.01% |
18,364
+3,532
| +24% | +$154K |
|
712
Vulcan Materials
VMC
$36.3B
| $805K | ﹤0.01% |
6,739
-172
| -2% | -$20.6K |
|
713
Provident Financial Services
PFS
$3.11B
| $802K | ﹤0.01% |
30,096
-1,050
| -3% | -$26.6K |
|
714
Revvity
RVTY
$12.3B
| $799K | ﹤0.01% |
11,590
+3,588
| +45% | +$241K |
|
715
T-Mobile US
TMUS
$193B
| $798K | ﹤0.01% |
12,964
+10,811
| +502% | +$678K |
|
716
Toronto Dominion Bank
TD
$198B
| $791K | ﹤0.01% |
14,078
+178
| +1% | +$9.35K |
|
|
GXP
717
DELISTED
Great Plains Energy Incorporated
GXP
| $791K | ﹤0.01% |
26,169
-116,005
| -82% | -$3.55M |
|
718
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $785K | ﹤0.01% |
20,239
+18,839
| +1,346% | +$734K |
|
719
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $784K | ﹤0.01% |
3,511
+100
| +3% | +$21.9K |
|
|
CLGX
720
DELISTED
Corelogic, Inc.
CLGX
| $777K | ﹤0.01% |
16,827
-195
| -1% | -$8.85K |
|
721
Bunge Global
BG
$23.6B
| $768K | ﹤0.01% |
11,072
-25,765
| -70% | -$1.95M |
|
|
BIVV
722
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $768K | ﹤0.01% |
13,470
-17,199
| -56% | -$1.01M |
|
723
PBF Energy
PBF
$7.29B
| $763K | ﹤0.01% |
27,660
-10,162
| -27% | -$235K |
|
724
iShares MSCI Japan ETF
EWJ
$21.7B
| $760K | ﹤0.01% |
13,660
+9,550
| +232% | +$521K |
|
725
JetBlue
JBLU
$1.96B
| $758K | ﹤0.01% |
40,961
-216
| -0.5% | -$4.53K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Glenmede Trust held 3,143 positions worth $22.8B, up 9% from $20.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust's Q3 2017 filing shows 326 new, 869 increased, 968 reduced and 274 closed positions. Its largest new stake was Five Below: 1,137,870 shares worth $62.4M. The largest sale was Du Pont De Nemours E I, an estimated $91.2M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- Glenmede Trust's largest Q3 2017 buy was Five Below: 1,137,870 shares worth $62.4M.
- Glenmede Trust added most to Constellation Brands in Q3 2017, an estimated $125M increase.
- Glenmede Trust's biggest Q3 2017 reduction was Tyson Foods, cutting an estimated $72.4M.
- Glenmede Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $91.2M.
- Glenmede Trust's ten largest holdings make up 15% of its $22.8B portfolio in Q3 2017.
- Glenmede Trust opened 326 new positions and closed 274 in Q3 2017.
- Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $22.8B.
Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.